December 12, 2023
Astellas Pharma said on December 11 that it has received European regulatory approval for Veoza (fezolinetant) for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, known as hot flashes or night sweats. The approval, granted on...read more